Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beat Roth

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
The Journal of Clinical Investigation|March 2, 2026
Deep biochemical phenotyping reveals prognostic value of rare genetic variants in adult kidney stone diseaseJohannes Münch, Jana Petrovska, Joana Figueiro-Silva, et al.
BMC Nephrology|December 12, 2018
Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trialNasser A Dhayat, Nicolas Faller, Olivier Bonny, et al.
The New England Journal of Medicine|March 1, 2023
Hydrochlorothiazide and Prevention of Kidney-Stone RecurrenceNasser A Dhayat, Olivier Bonny, Beat Roth, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 10, 2025
Hydrochlorothiazide and Bone Mineral Density in Patients with Kidney Stones: Post Hoc Analysis of the NOSTONE TrialAndreas Christe, Elias Primetis, Grazia M Cereghetti, et al.
World Journal of Urology|September 19, 2024
Follow-up strategies after trimodal treatment for muscle-invasive bladder cancer: a systematic reviewErnest Kaufmann, Stefanie Aeppli, Winfried Arnold, et al.
Bladder Cancer (Amsterdam, Netherlands)|January 19, 2026
Interdisciplinary Swiss consensus recommendations for follow-up after radical cystectomy and trimodal treatment for muscle-invasive bladder cancerErnest Kaufmann, Stefanie Aeppli, Andres Affentranger, et al.
BJU International|June 25, 2025
Enhanced prognostic value of four-tier hybrid grading system in Ta non-muscle-invasive bladder cancerMatteo Ferro, Michele Catellani, Roberto Bianchi, et al.
International Urology and Nephrology|January 3, 2026
Defining the optimal duration of maintenance mitomycin C in intermediate-risk Ta NMIBC: a multicenter retrospective landmark analysisRoberto Contieri, Letizia Maria Ippolita Jannello, Mihai Dorin Vartolomei, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
The Journal of Clinical Investigation|March 2, 2026
Deep biochemical phenotyping reveals prognostic value of rare genetic variants in adult kidney stone diseaseJohannes Münch, Jana Petrovska, Joana Figueiro-Silva, et al.
BMC Nephrology|December 12, 2018
Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trialNasser A Dhayat, Nicolas Faller, Olivier Bonny, et al.
The New England Journal of Medicine|March 1, 2023
Hydrochlorothiazide and Prevention of Kidney-Stone RecurrenceNasser A Dhayat, Olivier Bonny, Beat Roth, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 10, 2025
Hydrochlorothiazide and Bone Mineral Density in Patients with Kidney Stones: Post Hoc Analysis of the NOSTONE TrialAndreas Christe, Elias Primetis, Grazia M Cereghetti, et al.
World Journal of Urology|September 19, 2024
Follow-up strategies after trimodal treatment for muscle-invasive bladder cancer: a systematic reviewErnest Kaufmann, Stefanie Aeppli, Winfried Arnold, et al.
Bladder Cancer (Amsterdam, Netherlands)|January 19, 2026
Interdisciplinary Swiss consensus recommendations for follow-up after radical cystectomy and trimodal treatment for muscle-invasive bladder cancerErnest Kaufmann, Stefanie Aeppli, Andres Affentranger, et al.
BJU International|June 25, 2025
Enhanced prognostic value of four-tier hybrid grading system in Ta non-muscle-invasive bladder cancerMatteo Ferro, Michele Catellani, Roberto Bianchi, et al.
International Urology and Nephrology|January 3, 2026
Defining the optimal duration of maintenance mitomycin C in intermediate-risk Ta NMIBC: a multicenter retrospective landmark analysisRoberto Contieri, Letizia Maria Ippolita Jannello, Mihai Dorin Vartolomei, et al.
Pageof 14